Clinical Outcome Following the Use of Inadequate Solutions for Continuous Veno-Venous Hemodiofiltration

Basit Öğe Kaydı
dc.contributor.authorCelik, Jale Bengi
dc.contributor.authorTopal, Ahmet
dc.contributor.authorKartal, Elmas
dc.contributor.authorYosunkaya, Alper
dc.date.accessioned2020-03-26T17:26:30Z
dc.date.available2020-03-26T17:26:30Z
dc.date.issued2008
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractBackgrounds. A short time ago, commercially available diafiltration and replacement fluids could be found o n the hospital in Turkey. Instead, peritoneal dialysis solution (PDS) for continue veno-venous hemodiafiltration (CVVHDF) therapy and normal saline as replacement fluid are used. In this retrospective study, we investigated the effects of PDS and bicarbonate-buffered hemofiltration solution (Bic-HFS). Methods. We did a retrospective chart review of 24 patients treated with continue renal replacement therapy (CRRT) between January 2004 and February 2008. Peritoneal dialysis solution (PDS) was used in 14 patients, and bicarbonate-buffered hemodialysis solution (bic-HFS) was used in 10 patients. Results. Demographic data, laboratory findings, and mortality rate were similar both groups. Blood glucose and lactate levels were higher in the PD group than the bic-HFS group (p 0.05). Hyperglycemia occurred more frequent in the PDS group than in the bic-HFS group (64% versus 30%, respectively; p 0.05). Metabolic acidosis occurred in eight patients (57%) in the PDS group and three patients (30%) in the bic-HFS group (p 0.05). Hypotension was higher in the PDS group (10, 71%) than in the bic-HFS group (3, 30%; p 0.05). Conclusion. Using PDS fluid as dialysate for CVVHDF therapy is not a preferable solution because of the metabolic disturbances that it can cause.en_US
dc.identifier.doi10.1080/08860220802422028en_US
dc.identifier.endpage964en_US
dc.identifier.issn0886-022Xen_US
dc.identifier.issue10en_US
dc.identifier.pmid19016146en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage959en_US
dc.identifier.urihttps://dx.doi.org/10.1080/08860220802422028
dc.identifier.urihttps://hdl.handle.net/20.500.12395/22255
dc.identifier.volume30en_US
dc.identifier.wosWOS:000261019100003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherINFORMA HEALTHCAREen_US
dc.relation.ispartofRENAL FAILUREen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectdialysateen_US
dc.subjectcontinuous renal replacement therapyen_US
dc.subjectmetabolic disturbancesen_US
dc.titleClinical Outcome Following the Use of Inadequate Solutions for Continuous Veno-Venous Hemodiofiltrationen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu